Organogenesis’ Steven Bernitz
This article was originally published in The Gray Sheet
Executive Summary
Chief Operating Officer succeeds Michael Sabolinski as President/CEO. The former Merck executive oversaw development of FortaPerm and FortaGen products; Sabolinski will serve as VP/Regulatory Affairs...